Episodes 1-15 of 352
Diagnosing NTM and Bronchiectasis: Best Practices for Early and Accurate Recognition
Deep Breaths: Updates from CHESTDiagnosing NTM and Bronchiectasis: Best Practices for Early and Accurate Recognition
An Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Spotlight On Subcutaneous Cancer ImmunotherapiesAn Analysis of Subcutaneous Versus Intravenous Atezolizumab in NSCLC
Respiratory Challenges in Neuromuscular Disorders: A Look at Symptoms and Impacts
NeuroFrontiersRespiratory Challenges in Neuromuscular Disorders: A Look at Symptoms and Impacts
Navigating Neuromuscular Diseases: CHEST Guidelines for Respiratory Care
NeuroFrontiersNavigating Neuromuscular Diseases: CHEST Guidelines for Respiratory Care
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
NeuroFrontiersRespiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
CAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment
Living RheumCAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment
ILD in Rheumatic Diseases: Evolving Management Strategies
Living RheumILD in Rheumatic Diseases: Evolving Management Strategies
Optimizing NTM Care: Expert Insights on Diagnosis and Treatment
Deep Breaths: Updates from CHESTOptimizing NTM Care: Expert Insights on Diagnosis and Treatment
Implicit Bias in Uncontrolled Asthma Care: Impacts on Clinical Decision-Making
Deep Breaths: Updates from CHESTImplicit Bias in Uncontrolled Asthma Care: Impacts on Clinical Decision-Making
Targeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
On the Frontlines of Non-Small Cell Lung CancerTargeting HER2-Mutant NSCLC with Trastuzumab Deruxtecan: Initial Study Findings
Treating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
On the Frontlines of Non-Small Cell Lung CancerTreating Second-Line NSCLC: The Efficacy of ADCs Targeting Predictive Biomarkers
Dato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
On the Frontlines of Non-Small Cell Lung CancerDato-DxD for NSCLC: A Review of Final Overall Survival Data from TROPION-Lung01
Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
On the Frontlines of Non-Small Cell Lung CancerAnalyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases
Evaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
On the Frontlines of Non-Small Cell Lung CancerEvaluating Valemetostat and Dato-DXd for NSCLC: An Upcoming Trial
Treating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
On the Frontlines of Non-Small Cell Lung CancerTreating NSCLC with Durvalumab, Chemotherapy, and Novel Agents: Preliminary Results
